Larson Financial Group LLC Alkermes Plc. Transaction History
Larson Financial Group LLC
- $1.75 Billion
- Q3 2024
A detailed history of Larson Financial Group LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Larson Financial Group LLC holds 10 shares of ALKS stock, worth $317. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$317
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$924 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$602 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$413 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$402 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$292 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.22B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...